14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CBLI ranks #14380 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cleveland BioLabs Stock Forecast NASDAQ:CBLI

$2.30 (-8.00%)

Volume: 205k

Closed: Dec 03, 2021

Hollow Logo Score: -3.781

Cleveland BioLabs Stock Forecast

$2.30 (-8.00%)

Volume: 205k

Closed: Dec 03, 2021

Score Hollow Logo -3.781
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 14 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.

High volatility in Cleveland BioLabs stock price on Friday which ended trading at $2.30
(Updated on Dec 03, 2021)


Sell candidate since 2021-11-29 Loss -27.22%

The Cleveland BioLabs stock price fell by -8.00% on the last day (Friday, 3rd Dec 2021) from $2.50 to $2.30. and has now fallen 7 days in a row. During the day the stock fluctuated 10.62% from a day low at $2.26 to a day high of $2.50. The price has fallen in 7 of the last 10 days and is down by -29.23% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -109 thousand shares and in total, 205 thousand shares were bought and sold for approximately $470.58 thousand.

The stock has broken the very wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $2.43. A reaction back to this level may hold a second chance to get out before further falls.

Signals & Forecast

There are few to no technical positive signals at the moment. The Cleveland BioLabs stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.92 and $3.48. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, November 12, 2021, and so far it has fallen -43.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

Cleveland BioLabs finds support from accumulated volume at $2.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.24 between high and low, or 10.62%. For the last week the stock has had a daily average volatility of 14.15%.

Cleveland BioLabs is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Cleveland BioLabs stock A Buy?

The Cleveland BioLabs stock holds several negative signals and despite the positive trend, we believe Cleveland BioLabs will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.781

Predicted Opening Price for Cleveland BioLabs of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$2.35 $2.30 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 14.15 %
Overall Risk: Very High High Medium Low Very Low
Volatility
14.15 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $2.50
Price: $2.30
Support: $2.29

CBLI Insider Trading Show all Trades

INSIDER POWER

8.371

Last 100 transactions
Buy: 3 363 248 | Sell: 401 768 (Shares)
Date Action Amount Person Type
Jul 27, 2021 Buy 101 579 Selsky Clifford Common Stock, par value $0.005 per share
Jul 27, 2021 Buy 60 947 Mcavoy Cozette M. Common Stock, par value $0.005 per share
Jul 27, 2021 Buy 296 609 Handley Michael K Common Stock, par value $0.005 per share
Jul 27, 2021 Buy 24 378 Buckheit Robert Common Stock, par value $0.005 per share
Jul 27, 2021 Buy 141 370 Aronstam Peter Common Stock, par value $0.005 per share
Show all Insider Trades
INSIDER POWER

8.371

Last 100 transactions
Buy: 3 363 248 | Sell: 401 768 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 2.59 12.75 %
2.50 8.77 %
2.45 6.30 %
Current price: 2.30
Support 2.26 -1.67 %
2.21 -4.13 %
2.11 -8.12 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 2.84 23.48 %
2.69 16.96 %
2.50 8.70 %
Current price 2.30
Support 2.29 -0.43%
2.23 -3.04%
2.20 -4.35%

Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT